Gland Pharma (GLAND) Share Price rises 4.15% as stock trades at Rs 3,015.80
- September 3, 2026
- Posted by: Kunal Singla
- Category: News
Gland Pharma Share Price is trading at Rs 3,015.80, up 4.15% from the previous close, and the company’s market capitalisation stands at Rs 48,107.26 crore. The move places Gland Pharma Share Price among the stocks drawing attention in today’s Indian stock market, even though a company-specific catalyst is not established. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the day’s move a price action story first, with valuation and business context providing the next layer of interpretation. In Gland Pharma Stock News terms, the immediate focus is on how the share price rise compares with its opening level, intraday range and healthcare-sector benchmark. Investors tracking Gland Pharma Share Price Today can use Univest for live price context, valuation ratios and sector positioning.
Gland Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,015.8 |
| Previous Close | Rs 2,895.5 |
| Today's Move | Rs 120.3 (+4.15%) |
| Open | Rs 2,909.6 |
| High | Rs 3,020 |
| Low | Rs 2,909.6 |
| Market Capitalisation | Rs 48,107.26 crore |
| Market Cap Category | Large Cap |
Gland Pharma Ltd. (GLAND) rose to Rs 3,015.8 from the previous close of Rs 2,895.5, a move of Rs 120.3 or 4.15%. The stock opened at Rs 2,909.6, reached a high of Rs 3,020, recorded a low of Rs 2,909.6.
Gland Pharma Share Price rose 4.15% today, adding Rs 120.30 from the previous close and moving to Rs 3,015.80. The stock opened at Rs 2,909.60, touched a high of Rs 3,020, and also marked the same level as the day’s low, placing Gland Pharma Share Price firmly above the prior close in early trade. This Gland Pharma Share Price Today move is a clean price rise rather than a broad narrative shift, so the key question remains what the numbers show. In Gland Pharma Share Price Live terms, the stock has already moved through its opening level and is now trading near the day’s high. Univest data shows the price action clearly, while the next section turns to Gland Pharma Fundamental Analysis for the valuation backdrop behind the move.
Gland Pharma Ltd. (GLAND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 48,107.26 crore |
| P/E Ratio | 42.33x |
| P/B Ratio | 4.5x |
| ROE | 10.56% |
| ROCE | 14.96% |
| EPS | Rs 68.41 |
| Book Value Per Share | Rs 644.16 |
| Dividend Yield | 0.69% |
Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 42.33x, P/B 4.5x, ROE 10.56%, ROCE 14.96%. These ratios show where the company stands today and are not a call to buy or sell.
Gland Pharma Ltd. has a market capitalisation of Rs 48,107.26 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.33x, P/B at 4.5x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.69%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 42.33x |
| Benchmark Median P/E | 32.59x |
| Benchmark Average P/E | 49x |
| Benchmark P/E Range | 3.46x to 707.31x |
| Company P/B Ratio | 4.5x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 10.56% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 14.96% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 48,107.26 crore |
| Benchmark Median Market Cap | Rs 783.26 crore |
Gland Pharma Ltd. (GLAND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.33x, which is above the benchmark median of 32.59x, a difference of +29.89%. A P/E difference of this kind is a reference point rather than a recommendation.
Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.7%, a difference of -9.74%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.61%, a difference of +9.92%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 36.5 | 5.1 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,55,115.31 | 86.51 | 14.33 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,613.38 | 84.92 | 20.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,899.96 | 26.79 | 4.48 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Gland Pharma Ltd. (GLAND) has a P/E ratio of 42.33x compared with the displayed peer median of 36.5x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.56% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 48,107.26 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Gland Pharma
- Gland Pharma Share Price is trading higher by 4.15% today, making it a notable share price rise in the healthcare space.
- The stock is trading above the previous close, with the day’s high near Rs 3,020 and the current price near that level.
- Gland Pharma Fundamental Analysis shows a P/E of 42.33, P/B of 4.50 and ROCE of 14.96%, which keeps valuation in focus.
- The company’s market capitalisation of Rs 48,107.26 crore gives the move size and market cap relevance.
- Sector and peer comparisons show mixed positioning, so Gland Pharma Stock News is being watched for valuation context rather than a one-line narrative.
About Gland Pharma
Gland Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is known for its presence in injectable pharmaceuticals and related offerings, which place it within a specialised part of the Indian pharma market. For readers following Gland Pharma Share Price, the business context matters because this is not a broad consumer story; it is a company whose operating profile and valuation are read through company financials, product focus and industry positioning. Gland Pharma Share Price Today reflects how the market is valuing that business today, while Gland Pharma Latest News typically needs to be read alongside fundamentals such as EPS, book value, ROE and ROCE. Univest presents Gland Pharma Company News and Gland Pharma Stock Performance in the same place so investors can connect the business model with the share price move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Gland Pharma Share Price rising today?
Ans. Gland Pharma Share Price is higher by 4.15% today, but no company-specific catalyst is established. According to latest Univest data, the move is confirmed through price action, with the stock trading at Rs 3,015.80.
What is the current Gland Pharma Share Price?
Ans. Gland Pharma Share Price is Rs 3,015.80. It is up Rs 120.30 from the previous close of Rs 2,895.50 and is trading near the day’s high of Rs 3,020.
What is Gland Pharma Share Price Today compared with the previous close?
Ans. Gland Pharma Share Price Today is 4.15% higher than the previous close. The stock opened at Rs 2,909.60, moved above the prior level and stayed close to the day’s high.
What does Gland Pharma Fundamental Analysis show?
Ans. Gland Pharma Fundamental Analysis shows a P/E of 42.33, P/B of 4.50, ROE of 10.56%, ROCE of 14.96%, EPS of 68.41 and book value of Rs 644.16. Dividend yield is 0.69%.
How is Gland Pharma valued versus the healthcare sector?
Ans. In the same-industry benchmark, Gland Pharma Share Price reflects a P/E above the median of 32.59 and a P/B above the median of 2.88. ROCE is above the benchmark median.
How does Gland Pharma compare with peers?
Ans. Compared with peers, Gland Pharma Share Price has a lower P/E than Divi’s Laboratories and Torrent Pharmaceuticals, but a higher P/B than Zydus Lifesciences. ROE trails several peer names.
What is Gland Pharma Market Cap today?
Ans. Gland Pharma Market Cap stands at Rs 48,107.26 crore. That size places the company well above the benchmark median market capitalisation in its industry sample. The company operates in the Healthcare sector.
Should investors track Gland Pharma Share Price on Univest?
Ans. Investors tracking Gland Pharma Share Price can use Univest for live price context, valuation ratios, sector comparison and company overview. It keeps Gland Pharma Stock News and fundamentals in one place.
Track Gland Pharma Share Price on Univest
Use Gland Pharma Ltd. (GLAND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors tracking Gland Pharma Share Price can follow the live share price, market cap, valuation ratios, 52-week levels and company overview on Univest. Gland Pharma Share Price Live and Gland Pharma Share Price Update are best understood when price action is viewed with P/E, P/B, EPS, book value and sector comparison together. Univest keeps Gland Pharma Stock Analysis and Gland Pharma Share News in one place so the current move stays connected to fundamentals and healthcare-sector context.
